WELLINGTON MANAGEMENT GROUP LLP
Position in AGIO — Agios Pharmaceuticals, Inc.
CIK 902219
Boston, MA
Position in AGIO
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$21,701,468
+$5,428,648 QoQ
Shares Held
641,486
+7.3% QoQ
Ownership
1.08%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0%
Shared 82%
None 18%
Common Shares in AGIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026WELLINGTON MANAGEMENT GROUP LLP holds $14,419,413,768 across 180 Biotechnology names. AGIO ranks #61 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
3,212,589 | $1,434,549,489 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,837,459 | $1,419,694,318 | |
| 3 | ARGX |
Argenx SE
|
1,021,457 | $745,918,971 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,935,925 | $640,539,501 | |
| 5 | RVMD |
Revolution Medicines, Inc.
|
6,027,819 | $586,205,394 | |
| 6 | CYTK |
Cytokinetics Inc
|
8,009,489 | $527,905,416 | |
| 7 | IONS |
Ionis Pharmaceuticals Inc
|
6,391,816 | $479,961,458 | |
| 8 | ASND |
Ascendis Pharma A/S
|
1,757,633 | $402,023,391 |
All Filings in AGIO
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,701,468 | 641,486 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $16,272,820 | 597,826 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $99,202,636 | 2,471,416 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $14,040,008 | 422,129 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $716,734 | 24,462 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $837,567 | 25,489 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $1,308,373 | 29,448 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $1,570,385 | 36,419 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,165,036 | 39,844 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,012,549 | 45,467 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $128,676,808 | 5,199,063 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $166,114,584 | 5,865,628 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $131,460,317 | 5,723,131 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $153,391,407 | 5,462,657 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $145,597,119 | 5,148,413 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $114,140,316 | 5,148,413 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $149,874,756 | 5,148,566 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $169,233,364 | 5,148,566 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $239,165,590 | 5,182,353 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $373,078,992 | 6,769,715 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $353,919,696 | 6,853,596 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $341,326,439 | 7,877,370 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $276,857,280 | 7,910,208 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $420,720,581 | 7,866,877 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $279,604,431 | 7,880,621 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||